Cargando…
Targeted Therapies and Developing Precision Medicine in Gastric Cancer
SIMPLE SUMMARY: Stomach cancers remain highly aggressive cancers with poor patient outcomes; however, in the last two decades there has been a lot of clinical research into understanding targets and potential for targeted treatments in advanced stomach cancers, with some treatments that have already...
Autores principales: | Pihlak, Rille, Fong, Caroline, Starling, Naureen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296575/ https://www.ncbi.nlm.nih.gov/pubmed/37370858 http://dx.doi.org/10.3390/cancers15123248 |
Ejemplares similares
-
Germline mutations in pancreatic cancer and potential new therapeutic options
por: Pihlak, Rille, et al.
Publicado: (2017) -
Advances in Molecular Profiling and Categorisation of Pancreatic Adenocarcinoma and the Implications for Therapy
por: Pihlak, Rille, et al.
Publicado: (2018) -
The Role of ctDNA in Gastric Cancer
por: Mencel, Justin, et al.
Publicado: (2022) -
Precision medicine in gastric cancer
por: Bonelli, Patrizia, et al.
Publicado: (2019) -
Targeting FGFR2 Positive Gastroesophageal Cancer: Current and Clinical Developments
por: Gordon, Anderley, et al.
Publicado: (2022)